EUVIMEDEUVIMED entdecken
Crossref

Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effectiveness Analysis

B Bersu Ozcan, Yin Xi, Basak E Dogan

Academic Radiology · 2024-01 · 31 (1) · 121-130

DOI: 10.1016/j.acra.2023.08.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Radiology, 2024-01. Verfasst von B Bersu Ozcan und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Southwestern Medical Center, Department of Radiology, 5323 Harry Hines Boulevard, Dallas, TX 75390-8585 (B.B.O., Y.X., B.E.D.). E…. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Quality of Life. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE AND OBJECTIVES: To evaluate the cost-effectiveness of utilizing supplemental optoacoustic ultrasound (OA/US) versus gray-scale ultrasound (US) alone to differentiate benign and malignant breast masses in a diagnostic setting. MATERIALS AND METHODS: We created a decision-tree model to compare the cost-effectiveness of OA/US and US from the perspective of the US healthcare system. We utilized diagnostic test performance parameters from the PIONEER-01(NCT01943916) clinical trial and cost parameters (USD) from the Truven Health MarketScan Databases. Utility (quality adjusted life year, QALY) values were determined following published patient-reported outcomes. Cost-effectiveness was calculated through incremental cost-effectiveness ratio (USD/QALY, ICER) and net monetary benefit (NMB) in a Markov chain model. Deterministic and probabilistic sensitivity analyses were performed to determine the significance of variation in input parameters. A willingness-to-pay (WTP) threshold of $100,000/QALY was used for the study. RESULTS: OA/US had an estimated cumulative cost of $16,617.36 and the outcome of 16.85 QALYs in the 25-year period. The incremental NMB for OA/US was $1495.36, and the ICER was -$31,715.82/QALY, indicating that supplemental use of OA/US was more cost-effective than US alone. In the deterministic sensitivity analysis, when the cost of OA/US exceeded $1030.61 or the sensitivity of OA/US fell below 79.7%, or the specificity fell below 30.5%, the US alone strategy yielded higher NMB values compared to supplemental OA/US. According to probabilistic sensitivity analysis, OA/US was the better strategy in 98.69% of 10,000 iterations. CONCLUSION: OA/US is more cost-effective than US to differentiate benign or malignant breast masses in the diagnostic setting. It can reduce costs while improving patients' quality of life, primarily by reducing false-positive results with consequent benign biopsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Effectiveness AnalysisQuality of LifeHumansCost-Benefit AnalysisBreastDiagnostic Imaging

Stichwörter der Autor:innen

Breast cancerCost-effectivenessOptoacoustic ultrasound

Autor:innen und Institutionen

  • University of Texas Southwestern Medical Center, Department of Radiology, 5323 Harry Hines Boulevard, Dallas, TX 75390-8585 (B.B.O., Y.X., B.E.D.). Electronic address: BeratBersu.Ozcan@utsouthwestern.edu.
  • University of Texas Southwestern Medical Center, Department of Radiology, 5323 Harry Hines Boulevard, Dallas, TX 75390-8585 (B.B.O., Y.X., B.E.D.); University of Texas Southwestern Medical Center, Department of Populati…
  • University of Texas Southwestern Medical Center, Department of Radiology, 5323 Harry Hines Boulevard, Dallas, TX 75390-8585 (B.B.O., Y.X., B.E.D.).

Zitieren

APA

Ozcan, B. B., Xi, Y., & Dogan, B. E. (2024). Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effectiveness Analysis. Academic Radiology, 31(1), 121-130. https://doi.org/10.1016/j.acra.2023.08.042

Vancouver

Ozcan BB, Xi Y, Dogan BE. Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effectiveness Analysis. Academic Radiology. 2024;31(1):121-130. doi:10.1016/j.acra.2023.08.042

BibTeX
@article{Ozcan2024,
  author = {Ozcan, B Bersu and Xi, Yin and Dogan, Basak E},
  title = {Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effectiveness Analysis},
  journal = {Academic Radiology},
  year = {2024},
  volume = {31},
  number = {1},
  pages = {121--130},
  doi = {10.1016/j.acra.2023.08.042}
}
Kostenlos starten →